Objective: To evaluate the benefit of colony-stimulating factor-1 (CSF-1) adjuvant therapy to poor responders during a controlled ovarian hyperstimulation (COH) cycle.
Design: Prospective clinical study.
Setting: University hospital, general hospital, and private IVF clinic in Japan.